Shares of ImmuPharma plc (LON:IMM – Get Free Report) dropped 0.1% during mid-day trading on Monday . The company traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.67 ($0.04). Approximately 28,360,365 shares were traded during trading, a decline of 9% from the average daily volume of 31,251,598 shares. The stock had previously closed at GBX 3.67 ($0.04).
ImmuPharma Trading Down 7.4 %
The business’s fifty day simple moving average is GBX 1.44 and its 200-day simple moving average is GBX 1.65. The firm has a market cap of £14.16 million, a P/E ratio of -340.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Further Reading
- Five stocks we like better than ImmuPharma
- The Risks of Owning Bonds
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What Makes a Stock a Good Dividend Stock?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
